Abstract
A preliminary characterization of the immunopharmacological profile of the new immunomodulating agent FCE 20696 (6H,6 [2-(dimethylamino)-ethoxycarbonyl]-dibenzo[b,d]pyran-HCl) was performed in mice.
Single i.p. doses of this chemical, concomitantly given with the antigen, increased the antibody response and decreased the delayed hypersensitivity reaction to a suboptimal dose of SRBC, the active doses ranging from 6.25 to 50 mg/kg. No activity was observed using a full antigen dose. Macrophage cytotoxic activity was enhanced 2–4 days after a single i.p. treatment with 50 and 10 mg/kg. Spleen cell proliferation to T and B mitogens was inhibited by a single dose of 30 mg/kg given i.p. 6 days before the test, or by 10 mg/kg×3 days ending one day before the test. Finally, generation of suppressor cells was enhanced by the compound, given p.o. biweekly for at least 7 weeks, at doses ranging from 0.1 to 10 mg/kg. Collectively taken, these data suggest that FCE 20696 has a broad range of immunomodulating activities and that macrophages and suppressor cells are presumed to be the main targets of its pharmacological activity.
Abbreviations
- SRBC:
-
sheep red blood cells
- DH:
-
delayed hypersensitivity
- MTT:
-
(3-(4,5-dimethylthiazol-1-yl)-2,5-diphenyl tetrazolium bromide)
- Con A:
-
concanavalin A
- PHA:
-
phytohemagglutinin
- LPS:
-
lipopolysaccharide
- CCA:
-
N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt
- [3H]TdR:
-
methyl-3H-Thymidine
- CNS:
-
central nervous system
References
J. W. Hadden and F. Spreafico,New strategies in Immunotherapy. Springer Semin. Immunopathol.8, 321–326 (1985).
A. M. Isetta, M. C. Fornasiero, M. Ferrari and D. Trizio,Activity of the immunomodulator FCE 20696 on experimental models of autoimmunity. Int. J. Immunopharmacol.7, 389 (1985).
M. A. Verini and D. Ungheri,FCE 20696, a new synthetic immunomodulator, activity in models of viral and bacterial pathology. Immunopharmacology, in press.
I. Brandslund, H. C. Siersted, J. C. Jensensius and S. E. Svehag,Detection and quantitation of immune complexes with rapid polyethylene glycol precipitation complement consumption method. Methods in Enzymology vol. 74 (Eds. J. J. Langone and H. Van Vunakis) pp. 551–557, Academic Press, New York 1981.
P. H. Lagrange, G. B. Mackaness and T. E. Miller,Potentiation of T cell mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. Exp. Med.139, 1529–1539 (1974).
D. Boraschi, D. Soldateschi and A. Tagliabue,Macrophage activation by interferon; dissociation between tumoricidal capacity and suppressive activity. Europ. J. Immunol.12, 320–326 (1982).
T. Mosmann,Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods65, 55–63 (1983).
D. Trizio, C. Della Bruna and A. M. Isetta,Modification of immune responsiveness in murine Schistosomiasis mansoni. I. Time course after cercarial exposure. Immunology40, 353–358 (1980).
R. R. Rich and S. Solliday-Rich,Biological expression of lymphocyte activation. IV. Concanavalin A activated suppressor cells in mouse mixed lymphocyte reactions. J. Immunol.114, 1112–1115 (1975).
L. Binderup,Decreased T-suppressor cell activity in rats with adjuvant arthritis. Ann. Rheum. Dis.42, 693–698 (1983).
A. Ben Nun and I. R. Cohen.Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector cell recovered as T cell lines. J. Immunol.128, 1450–1457 (1982).
J. S. Moore and C. E. Calkins,In vitro regulation of the pathogenic autoantibody response of New Zealand Black mice. I. Loss with age of suppressive activity in T cell populations. J. Immunol.134, 3838–3845 (1985).
D. O. Adams and A. T. Hamilton,The cell biology of macrophage activation. Annual Rev. Immunol.2, 283–318 (1984).
H. Kirchner, B. R. Fembach and R. B. Herberman,Macrophages suppressing T and B mitogen responses and the mixed leukocyte reaction. Mitogens in Immunology. (Eds. J. J. Oppenheim and D. L. Rosenstreich) pp. 495–507, Academic Press, New York 1976.
Z. Metzger, J. T. Hoffeld and J. J. Oppenheim,Macrophagemediated suppression. I. Evidence for partecipation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol.124, 983–988 (1980).
W. Ptak, M. Zembala, G. L. Asherson and J. Marcinkiewicz,Inhibition of contact sensitivity by macrophages. Int. Arch. Allergy Appl. Immunol.65, 121–126 (1981).
L. Varesio and H. T. Holden,Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.Cell Immunol. 56, 16–28 (1980).
A. Santoni, C. Riccardi, T. Barlozzari and R. B. Herbermann,Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer. Int. J. Cancer26, 837–845 (1980).
R. M. Schultz, J. R. Schimidtke and A. G. Johnson,Role of macrophages in immunopotentiation by Adjuvants. The Reticuloendotelial System, vol. 6 (Eds. H. Friedman, M. Escobar and M. S. Reichard) pp. 319–337, Plenum Press, New York 1984.
M. A. Verini,Mechanism of antiviral activity of a new synthetic immunomodulator. Int. J. Immunopharmacol.7, 389 (1985).
M. C. Fornasiero, A. M. Isetta, M. Ferrari and D. Trizio,Antigen specific suppressor cells induced by the immunomodulator FCE 20696 in aged NZB/WF 1 mice. Agents and Actions19, 315–317 (1986).
T. Nakano, Y. Yamashita, Y. Ohsugi, Y. Sugawara, S. Hata and Y. Takagaki,The effect of CCA (Lobenzarit disodium) on the suppressor T cells function and the production of autoantibodies in New Zealand Black and New Zealand White F 1 mice. Immunopharmacology5, 293–302 (1983).
I. Yamamoto, H. Ohmori and M. Sasano,CCA: an immunopharmacological profile “in vivo” and “in vitro”. Drugs Exptl. Clin. Res.1, 5–10 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Isetta, A.M., Fornasiero, M.C., Ferrari, M. et al. FCE 20696, a new synthetic immunomodulator: Immunopharmacological profile. Agents and Actions 28, 283–289 (1989). https://doi.org/10.1007/BF01967416
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01967416